BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 45.34
-0.67 (-1.46%)
At close: Feb 13, 2026
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 19.17 billion as of February 13, 2026. Its market cap has increased by 52.99% in one year.
Market Cap
19.17B
Enterprise Value
20.99B
Revenue
1.18B
Ranking
n/a
PE Ratio
308.76
Stock Price
45.34
Market Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 19.17B, an increase of 52.72%. That is a compound annual growth rate of 6.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 19.17B | -7.58% |
| Dec 31, 2025 | 20.74B | 62.70% |
| Dec 31, 2024 | 12.75B | -13.79% |
| Dec 29, 2023 | 14.79B | 55.07% |
| Dec 30, 2022 | 9.54B | -36.65% |
| Dec 31, 2021 | 15.05B | -19.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hualan Biological Engineering | 28.29B |
| Suzhou Zelgen Biopharmaceuticals | 25.49B |
| Yili Chuanning Biotechnology | 25.27B |
| DaShenLin Pharmaceutical Group | 22.08B |
| Sinocelltech Group | 18.00B |
| Inner Mongolia Furui Medical Science | 17.60B |
| Jinyu Bio-technology | 17.24B |
| Anhui Anke Biotechnology (Group) | 16.60B |